Show
Sort by
-
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
-
Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure
-
- Journal Article
- A1
- open access
FibroSURE™ and FibroScan® in relation to treatment response in chronic hepatitis C virus
-
Randomized placebo controlled phase I/II trial of α-galactosylceramide for the treatment of chronic hepatitis C